[Gastrin-17 level in the omeprazole treatment of duodenal ulcer].
The article discloses the results of the duodenal ulcer treatment with a generic of omeprazole (Omizac) in the in-patient hospital and polyclinic conditions, dynamics of the serum gastrin level against the background of the drug application and after its withdrawal, and assessment of the intensity and duration of acid production inhibition in the stomach.
Belov
D F
DF
Maksimova
I D
ID
Ponomarev
A A
AA
Loginov
A F
AF
D000328:Adult; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004381:Duodenal Ulcer / Q000097:blood* / Q000188:drug therapy; D005260:Female; D005755:Gastrins / Q000097:blood*; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D015415:Biomarkers; D005755:Gastrins; C013550:gastrin 17; D009853:Omeprazole